Pharmacotherapy Issues in the Pediatric Population

Similar documents
Are Pediatric Patients Small Adults?

Medication use in children

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

PRINCIPLES OF PEDIATRIC PHARMACOTHERAPY. Marianne Krupicka, Pharm.D. Oregon Health and Science University/ Doernbecher Children s Hospital

Clinical Impact of Pharmaceutical Care Services in Pediatric and Neonatal Intensive Care Unit. Amanda Li Clinical Pharmacist Queen Mary Hospital

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Frequently Asked Questions

BIOPHARMACEUTICS and CLINICAL PHARMACY

Pharmacokinetics in pediatric population

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 1 PharMEDium Lunch and Learn Series LUNCH AND LEARN

DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: p. 37 TOP: NURSING PROCESS: General MSC: NCLEX: Health Promotion and Maintenance

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital

Pediatric Drug Development Current Challenges

Dosage Calculation - Worksheet

Calculation of Medications for Special Populations Based on Body Weight and Patient Age

The P&T Committee Lisinopril (Qbrelis )

Drug dosing in Extremes of Weight

Pharmacovigilance Paediatric Perspective

PAIN PODCAST SHOW NOTES:

Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN

Clinical Study Synopsis for Public Disclosure

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

DEVELOPMENTAL PK/PD: WHAT HAVE WE LEARNT? Geoff Tucker

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

When you drink, your baby drinks too. Drinking alcohol during

BASIC PHARMACOKINETICS

ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Chapter Questions. Modern Pharmacology With Clinical Applications. Sixth Edition

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Clinical Calculation 5 th Edition

Pharmacokinetics in the critically ill. Intensive Care Training Program Radboud University Medical Centre Nijmegen

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

One-Compartment Open Model: Intravenous Bolus Administration:

PHARMACOKINETICS SMALL GROUP I:

Cox College Springfield, MO. Dosage Calculation Competency Level II Practice Sheet STUDENT NAME: DATE: STUDENT I.D. #: ADVISOR:

Recommended dosing for pediatric patients (6 months to 12 years of age) 1. Dose based on lopinavir component* 1.25 ml ml

This letter is to notify you of recent changes to the TAMIFLU product monograph. Please note, additions/changes have been highlighted in yellow.

Pediatric Compounding. Erika Fallon, PharmD/RPh

ROSOBAC-1GM / ROSOBAC-FORT

Lecture 5: Principles of Drug Administration Drug Therapy in Special Populations Objectives

Renal Excretion of Drugs

PATIENT INFORMATION LEAFLET

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.

Unit 2b: EXCRETION OF DRUGS. Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK)

Paramedic Pediatric Medical Math Practice

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

PATIENT INFORMATION LEAFLET

A Layperson s Guide to Pediatric Formulation Development

1. If the MTC is 100 ng/ml and the MEC is 0.12 ng/ml, which of the following dosing regimen(s) are in the therapeutic window?

Nonparenteral medications

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

SUMMARY OF PRODUCT CHARACTERISTICS

Name Date Period. West Nomogram

4WS Neurology. Table of Contents

Drug Therapy Following Bariatric Surgery

DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA

PEDIATRIC PHARMACOTHERAPY A Monthly Newsletter for Health Care Professionals from the University of Virginia Children s Hospital

Section 5.2: Pharmacokinetic properties

Introduction to Pharmacokinetics

2 : In both figures, 1 is the numerator. and 2 is the denominator. 2/5 or 2 : In both figures, 2 is the numerator. and 5 is the denominator.

PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES

UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES. BSc (HONS) ADULT NURSING SEMESTER TWO EXAMINATION 2017/2018

Calculations. Doses and Dosage Regimens. Pharmacy Technician Training Systems Passassured, LLC

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

Odefsey. (emtricitabine, rilpivirine, tenofovir alafenamide) New Product Slideshow

New Zealand Datasheet

Compounding KI for Radiation Exposure

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

Pharmaceutical Care for Geriatrics

Aging Changes That Impact Medication Management

NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING FOR GENERAL PRACTICE

Useful Medications for Oral Conditions *

Pharmaceutical Calculations

Using Ratio and Proportion

DOES ACETAMINOPHEN 500 MG MAKE YOU SLEEPY

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Antivirals for Avian Influenza Outbreaks

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Systematic Approach to Answering Drug Information Questions

URSOSAN 250mg capsule, hard

Pharmacokinetics One- compartment Open Model Lec:2

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PATIENT INFORMATION LEAFLET

Drug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room

Ratios and Proportions. Jessica Tagerman, PharmD, RPh

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

PART VI: SUMMARY OF THE RISK MANAGEMENT PLAN

pharmacy, we need to see how clinical pharmacokinetics fits into the pharmaceutical care process.

PHARMACEUTICAL INFORMATION AZILSARTAN

RISK FACTORS AND DRUG TO STATIN-INDUCED MYOPATHY

PFIZER INC. PROPRIETARY DRUG NAME /GENERIC DRUG NAME: Cerebyx / Fosphenytoin Sodium

ZOFRAN TABLETS GlaxoSmithKline

Clodronate BE/H/PSUR/001/001 October 2011 Agreed CSP

Gastrointestinal-Specific and General Physiology Issues in Pediatrics: Implications for Pediatric Formulation Development

Transcription:

Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014

Outline Didactic Session General Pediatrics Pharmacy dispensing issues in pediatric patients Preventing medication errors in pediatric patients Small group case work Case Discussions

Learning Objectives Apply pharmaceutical care principles to solve patient cases specific to pediatrics (including dosage forms and regimens, and counseling points) Recommend an appropriate empiric antibiotic regimen for otitis media and UTI in a pediatric patient Calculate an appropriate dose for a pediatric patient based on weight Discuss error reduction strategies available to pharmacists to minimize mediation errors in pediatric patients Describe 3 clinical pearls relating to pediatric medicine

Definitions Pediatrics: Specialty of medical science concerned with the physical, mental and social health of children from birth to young adulthood Encompasses a broad spectrum of health services ranging from preventative health care to the diagnosis and treatment of acute and chronic diseases http://www.pedjobs.org/pdf/aap_definition_pediatrician.pdf

Definitions Neonate Birth to 1 month (28 days) Infant 1 month to 12 months (1 year) Child 1 year to 12 years Adolescent 13 years to <20 years (<18 years) Adult >18 years

What Makes Pediatrics Unique?? Physical Cognitive/Psychological Behavioural

Growth & Development Growth: Physical changes in size Development: Changes in function

http://www.health.gov.bc.ca/pho/pdf/who-pediatric-growth-charts.pdf

Vitals Age HR (BPM) SBP (mmhg) RR (Breaths per minute) Newborn 120-150 60-70 30-60 6 Months 120-140 65-120 25-35 1 Year 120-140 70-120 20-30 5 Years 90-110 80-125 20-25 15 Years 60-90 110-130 15-20

Pharmacy Dispensing Issues in Pediatrics

Dosage Forms/Formulations Liquid dosage forms preferred to crushing tablets but also have complications Ensure parents instructed to measure dose Provide measuring tool Parents to ensure children swallow medicine Beware of crushing certain medications Always check reliable reference

Convenience Need to individualize dosing regimens? Cloxacillin capsules PO QID AC (6 year old child) How can the child take when at school? Can you use your knowledge of pharmacology/pharmacokinetics/pharmaceutics to suggest a more convenient, effective agent?

Understanding You are dispensing a prescription for salbutamol to an 8 year old child newly diagnosed with asthma. She and her mother are waiting. Who do you talk to? What do you say? How do you counsel?

Preventing Medication Errors in Pediatric Patients

Adverse Drug Events Medication errors in pediatric patients are approximately 3 times more likely compared to adults ¾ of these errors occur in the medication ORDERING phase Fortescue E, et al. Pediatrics. 2003;111(4 pt 1):722 9. Kaushal R, et al. JAMA. 2001;285:2114 20.

Reasons for Increased Risk 1. Different and changing pharmacokinetic parameters 2. Lack of pediatric formulations, dosage forms, guidelines, and inconsistent measurement of preparations 3. Calculation errors

1. Different and changing PK parameters

Pediatric Pharmacokinetics Absorption Distribution Metabolism Excretion

Absorption Physiological Change Stomach ph varies from 6 to 8 at birth Gastric acid secretion is lower in premature infants Adult values of gastric ph are reached after approximately 3-5 years Variable muscle blood flow, reduced muscle tone and contractions Greater skin hydration and thinner stratum corneum PK Consequence Higher gastric ph in pediatrics Reduced dissolution of weak bases Enhanced dissolution of weak acids Increased bioavailability of acid-labile drugs such as ampicillin and naficillin Increased absorption of weak bases and reduced absorption of weak acids Reduced drug absorption from IM injections Enhanced drug absorption from topical preparations Nader A. Pediatric Pharmacokinetics. 2014

NEJM 2003;349:1157-67

NEJM 2003;349:1157-67

Distribution Physiological Change Proportion of water in premature babies is 85% of body weight, drops to 80% in full-term babies and 50-70% in adults Albumin and total protein concentrations are lower in newborns PK Consequence Increased body water and reduced body fat in infants and children Higher volume of distribution for water-soluble drugs (eg. aminoglycosides) and lower distribution for lipophilic drugs (eg. phenobarbital) Reduced plasma protein binding and increased tissue distribution Adult values reached at 10-12 months

NEJM 2003;349:1157-67

Hepatic Clearance Physiological Change Drug conjugation and biliary excretion are immature in newborns CYP450 enzyme activities in newborns are 30-50% that of adult values PK Consequence Increased drug exposure for drugs that are conjugated or excreted in bile Reduced clearance for drugs that are CYP450 metabolized Omeprazole (CYP2C19 CYP1A2 (Caffeine) Little fetal activity Adult activity by 4-5 months CYP2C9 (warfarin, phenytoin) Little activity at birth Adult activity early after birth CYP2D6 (dextromethorphan) Acquired within 2 weeks of birth Adult activity at 10 years CYP3A4 (midazolam) Exceeds adult levels by 1 year and until puberty

NEJM 2003;349:1157-67

Renal Clearance Physiological Change The majority of functioning tubular cells is reduced at birth, as are tubule length, blood flow to the peritubular area, and energy supply processes Immature glomerular filtration in newborns; reach adult values by 1 month for GFR GFR = 2-4mL/min at birth = 8-20mL/min by 3 days = 100mL/min by 1 month PK Consequence Reduced drug clearance dependent on glomerular filtration and renal active secretion of elimination (eg. penicillin) Ampicillin half-life by age group: One week 4 hours Two weeks 2.8 hours One month 1.7 hours Inverse correlation of elimination halflife with age (eg. aminoglycosides)

NEJM 2003;349:1157-67

PK Case 1 A premature infant (29 weeks of gestation) developed lethargy, apnea and metabolic acidosis in association with elevated serum concentrations of propylene glycol Thoughts??

PK Case 1 The infant had received topical therapy with nitrofurazone dissolved in propylene glycol

PK Case 2 A newborn infant developed difficulty breastfeeding and increasing lethargy at 7 days of age. 4 days later, he was taken to the clinic due to parents concerns about his pale skin color and decreased milk intake. 2 days after the clinic visit, an ambulance team found the baby cyanotic and without vital signs. Resuscitation was necessary Thoughts??

PK Case 2 The infant has severe morphine toxicity after codeine use to treat mother s pain

2. Lack of pediatric formulations, dosage forms, guidelines, and inconsistent measurement of preparations

Lack of Pediatric Formulations May lead to: Crushing tablets Opening capsules and adding to food or beverage Uses IV formulations for PO Administering medications rectally Compounding extemporaneous products

Lack of Pediatric Formulations Pitfalls of altering adult formulations Insufficient data to fully support practice Expiry dates??? Bioavailability Compounding errors

Sources of Errors Confusion among oral liquid concentrations Eg. Acetaminophen products 100 mg/ml Infant drops 160 mg/5ml Children s liquid 167 mg/5ml Adult extra strength Look-alike and sound-alike packaging and names Different dosing styles Eg. daily dosing versus every hours Acetaminophen 10-15 mg/kg/dose q6h Ampicillin 100-200 mg/kg/day divided q6h

Oral Measuring Devices Oral medications are more likely to be dispensed in bulk and not in unit dose Many households still use kitchen spoons for measuring Pre-packaged dispensing cups or droppers Often mistaken for whole doses versus measured doses

3. Calculation Errors

Calculation Errors There is NO standard dose All doses are recommended based on: Body weight in kilograms Body Surface Area

Convert Your patient weighs 28 lbs How many kilograms are they?

Calculations Patient weight: 45 lbs Give 40 mg/kg/day divided q8h How many mg per dose? How much is the 24 hour drug total?

Calculations and Supply MD order is to give 75 mg Supply is 160mg/5mL Calculate the amount to administer

Reduction of Calculation Errors Establish reliable method of providing current patient weight in kg to the health care team Require calculated dose and dose per weight (i.e., mg/kg) on each order Acetaminophen 100 mg (10 mg/kg) every 6 hours by mouth Exceptions Vitamins, topicals, other medications not requiring weightbased dosing Require independent double check of dosing calculations

Reduction of Calculation Errors Standardize dosing and concentrations IV drip rates or concentrations Recipes and strengths for extemporaneous compounds Provide pediatric references in ordering, dispensing, and administration locations Encourage rounding to whole numbers when possible

Reduction of Calculation Errors Include warnings for potentially low or high doses in the pharmacy Appropriately use decimal points Utilize leading zeros: 0.1 (right).1 (wrong) Do not use trailing zeros: 1 (right) 1.0 (wrong)

Summary Pediatric patients are NOT small adults Physiologic differences can affect drug therapy Pediatric patients are at a greater risk of medication errors Variable PK Lack of dosage availability Calculations Measuring devices

Learning Objectives Apply pharmaceutical care principles to solve patient cases specific to pediatrics (including dosage forms and regimens, and counseling points) Recommend an appropriate empiric antibiotic regimen for otitis media and UTI in a pediatric patient Calculate an appropriate dose for a pediatric patient based on weight and body surface area Discuss error reduction strategies available to pharmacists to minimize mediation errors in pediatric patients Describe 3 clinical pearls relating to pediatric medicine

References http://www.health.gov.bc.ca/pho/pdf/who-pediatric-growthcharts.pdf Anatomic and Physiologic Differences Between Children and Adults. Dr. Elizabeth Farrington Fortescue EB et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003;111(4 Pt 1):722-9. Kaushal R et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285(16):2114-20. Kearns GL et al. Developmental pharmacology drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349(12):1157-67. http://www.pedjobs.org/pdf/aap_definition_pediatrician.pdf Pediatric Pharmacokinetics. Dr. Ahmed Nader, College of Pharmacy, Qatar University